CD8A and neoplasm: Neoadjuvant chemotherapy and NAIT operate on different biological mechanisms: the former delivers cytotoxic drugs to tumor cells via the bloodstream to destroy them, while the latter stimulates the body's immune system to promote the infiltration of killer immune cells (such as CD8+ T cells) into the tumor, thereby achieving tumor destruction.